Access this book
Tax calculation will be finalised at checkout
Other ways to access
About this book
The book shows the fields in which PET offers new and unique information for the development of drugs (conception, toxicity, pharmacokinetics and metabolism, clinical research, and relations between clinical and biological effects) and evaluates fields in which PET may shorten the development time of drugs.
Audience: Professionals in the pharmaceutical industry in all areas of drug discovery and pharmacology, pre-clinical testing, pharmacokinetics and metabolism, clinical evaluation, registration and regulatory affairs. Government health authority representatives who assess data and documentation on new drug development and radiopharmaceuticals. Academic experts concerned with any of these areas.
Similar content being viewed by others
Keywords
Table of contents (31 chapters)
-
Psychiatry
-
Neurology
Editors and Affiliations
Bibliographic Information
Book Title: PET for Drug Development and Evaluation
Editors: D. Comar
Series Title: Developments in Nuclear Medicine
DOI: https://doi.org/10.1007/978-94-011-0429-6
Publisher: Springer Dordrecht
-
eBook Packages: Springer Book Archive
Copyright Information: Springer Science+Business Media Dordrecht 1995
Hardcover ISBN: 978-0-7923-3716-4Published: 30 November 1995
Softcover ISBN: 978-94-010-4191-1Published: 13 October 2012
eBook ISBN: 978-94-011-0429-6Published: 06 December 2012
Edition Number: 1
Number of Pages: VIII, 360
Topics: Imaging / Radiology, Nuclear Medicine, Pharmacology/Toxicology